Hirotomo Nakashima

Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2022, Leukemia & lymphoma.

Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysis.

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2021, Leukemia research.

Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.

S. Fujiwara, Kazuya Sato, M. Ashizawa, 2022, Leukemia research.

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation.

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2019, Blood advances.

Relapsed and refractory multiple myeloma: A systematic review and network meta‐analysis of the efficacy of novel therapies

S. Fujiwara, Kazuya Sato, M. Ashizawa, 2023, British journal of haematology.

Clinical association between thyroid disease and immune thrombocytopenia

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2020, Annals of Hematology.

Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2022, Internal medicine.

Daratumumab in first-line is cost-effective in transplant-eligible newly diagnosed myeloma patients.

S. Fujiwara, Kazuya Sato, R. Yamasaki, 2022, Blood.

Performance Improvement in User Verification Using Evoked Electroencephalogram by Imperceptible Vibration Stimuli

Isao Nakanishi, Hirotomo Nakashima, Yoshiaki Shindo, 2021, 2021 20th International Symposium on Communications and Information Technologies (ISCIT).

Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.

M. Ashizawa, Y. Kanda, D. Minakata, 2024, International journal of hematology.

Effects of CD34+ cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation

M. Ashizawa, Y. Kanda, D. Minakata, 2024, Clinical transplantation.

Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.

M. Ashizawa, Y. Kanda, D. Minakata, 2024, Leukemia & lymphoma.